medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2015, Number 3

<< Back Next >>

Ann Hepatol 2015; 14 (3)

Cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome

González-Moreno EI, Cámara-Lemarroy CR, Borjas-Almaguer DO, Martínez-Cabriales SA, Paz-Delgadillo J, Gutiérrez-Udave R, Ayala-Cortés AS, Ocampo-Candiani J, Cortéz-Hernández CA, Maldonado-Garza HJ

Language: English
References: 23
Page: 416-419
PDF size: 84.80 Kb.


ABSTRACT

Cutaneous amyloidosis is a rare disease characterized by the deposition of amyloid in the dermis. It can be primary or secondary, depending on associated diseases. It has been linked to various autoimmune diseases, including primary biliary cirrhosis. We present the case of a patient with an autoimmune hepatitis-primary biliary cirrhosis overlap syndrome with concomitant cutaneous amyloidosis, a very unusual association, and discuss similar cases and possible pathophysiological implications.


REFERENCES

  1. Borowicz J, Gillespie M, Miller R. Cutaneous amyloidosis. Skinmed 2011; 9: 96-100; quiz 1.

  2. Schreml S, Szeimies RM, Vogt T, Landthaler M, Schroeder J, Babilas P. Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement. Eur J Dermatol 2010; 20: 152-60.

  3. Rust C, Beuers U. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol 2008; 14: 3368- 73.

  4. Durazzo M, Premoli A, Paschetta E, Belci P, Spandre M, Bo S. Overlap syndromes of autoimmune hepatitis: an open question. Dig Dis Sci 2013; 58: 344-8.

  5. Desport E, Bridoux F, Sirac C, Delbes S, Bender S, Fernandez B, Quellard N, et al. Al amyloidosis. Orphanet J Rare Dis 2012; 7: 54.

  6. Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol 2011; 29: 1924-33.

  7. Erbagci Z, Erkilic S, Tuncel AA. Diffuse biphasic cutaneous amyloidosis in an HCV-seropositive patient: another extrahepatic manifestation of HCV infection? Int J Clin Pract 2005; 59: 983-5.

  8. Abe M, Kawakami Y, Oyama N, Nakamura-Wakatsuki T, Yamamoto T. A rare co-occurrence of primary localized cutaneous amyloidosis and chronic C type hepatitis. Int J Dermatol 2010; 49: 960-2.

  9. Saha A, Theis JD, Vrana JA, Dubey NK, Batra VV, Sethi S. AA amyloidosis associated with hepatitis B. Nephrol Dial Transplant 2011; 26: 2407-12.

  10. Ueno M, Yamamoto T, Yamanaka M, Matsunaga T. Nodular amyloidosis in a patient with liver cirrhosis. Dermatol Online J 2011; 17: 10.

  11. Rodriguez-Luna H, Vargas HE, Williams J, De Petris G, Rakela J, Douglas DD. Primary biliary cirrhosis and systemic amyloidosis, a new association. Dig Dis Sci 2004; 49: 1196-200.

  12. Parkash O, Almas A. Primary billiary cirrhosis (antimitochondrial antibody negative) leading to secondary amyloidosis. J Coll Physicians Surg Pak 2012; 22: 330-2.

  13. Kato T, Komori A, Bae SK, Migita K, Ito M, Motoyoshi Y, Abiru S, et al. Concurrent systemic AA amyloidosis can discriminate primary sclerosing cholangitis from IgG4-associated cholangitis. World J Gastroenterol 2012; 18: 192-6.

  14. Van Steenbergen W, Braeye L, Harlet R, Nevens F, Fevery J, Desmet V, Roskams S, et al. Primary sclerosing cholangitis complicated by amyloid A amyloidosis: complete regres419 Cutaneous amyloidosis associated with AIH-PBC overlap syndrome. , 2015; 14 (3): 416-419 sion of the nephrotic syndrome by liver transplantation. Eur J Gastroenterol Hepatol 2010; 22: 1265-70.

  15. Tafarel JR, Lemos LB, Oliveira PM, Lanzoni VP, Ferraz ML. Cutaneous amyloidosis associated with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2007; 19: 603-5.

  16. Dahdah MJ, Kurban M, Kibbi AG, Ghosn S. Primary localized cutaneous amyloidosis: a sign of immune dysregulation? Int J Dermatol 2009; 48: 419-21.

  17. Schwendiman MN, Beachkofsky TM, Wisco OJ, Owens NM, Hodson DS. Primary cutaneous nodular amyloidosis: case report and review of the literature. Cutis 2009; 84: 87-92.

  18. Kikuchi N, Sakai E, Nishibu A, Ohtsuka M, Yamamoto T. Primary localized cutaneous amyloidosis in patients with scleroderma. Acta Derm Venereol 2010; 90: 326-7.

  19. Yamamoto T, Suzuki Y. Primary localized cutaneous amyloidosis intermingled with papulopustular lesions in a patient with Behcet’s disease. Rheumatol Int 2012; 32: 3651-3.

  20. Kamada N, Yoneyama K, Togawa Y, Suehiro K, Shinkai H, Yokota M, Matsuda K, et al. Toxic epidermal necrolysis with severe hyperbilirubinemia: complete re-epithelialization after bilirubin reduction therapies. J Dermatol 2010; 37: 534-6.

  21. Washington MK. Autoimmune liver disease: overlap and outliers. Mod Pathol 2007; 20(Suppl. 1): S15-S30.

  22. Montano-Loza AJ, Lalor E, Mason AL. Recognizing immunoglobulin G4 related overlap syndromes in patients with pancreatic and hepatobiliary diseases. Can J Gastroenterol 2008; 22: 840-6.

  23. Cabibi D, Tarantino G, Barbaria F, Campione M, Craxi A, Di Marco V. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. Dig Liver Dis 2010; 42: 585-92.




2020     |     www.medigraphic.com